$DRTS

$13.18▲ -1.6% YTD

6 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

News

DRTS ▼ -1.6% - Alpha Tau Medical Ltd.

CP $13.18▲ -1.6%Oct 29, 2026 · ThinkSabio Blog

$DRTS DRTSW - Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange…

News

DRTS ▼ -0.4% - Alpha Tau Medical Ltd.

CP $13.43▲ -0.4%Oct 22, 2026 · ThinkSabio Blog

$DRTS DRTSW - Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea…

News

DRTS ▲ +7.8% - Alpha Tau Medical Ltd.

CP $13.26▲ +7.8%Oct 19, 2026 · ThinkSabio Blog

$DRTS DRTSW - Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2…

News

DRTS ▲ +0.7% - Alpha Tau Medical Ltd.

CP $14.89▲ +0.7%Oct 5, 2026 · ThinkSabio Blog

$DRTS DRTSW - Alpha Tau to Participate in October Investor Conferences…

News

DRTS ▲ +0.3% - Alpha Tau Medical Ltd.

CP $14.00▲ +0.3%Sep 2, 2026 · ThinkSabio Blog

$DRTS DRTSW - Alpha Tau to Participate in September Investor Conferences…

News

DRTS ▲ +0.8% - Alpha Tau Medical Ltd.

CP $14.76▲ +0.8%Aug 31, 2026 · ThinkSabio Blog

$DRTS DRTSW - Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand an…